PREMAPROB. Probiotics to Prevent Necrotizing Enterocolitis
NCT06501404 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 583
Last updated 2024-07-15
Summary
The main objective of this study is to assess the impact of two different doses of a mixture of probiotics from two strains isolated in human milk on the incidence of severe necrotizing enterocolitis (NEC) and death among preterm infants of gestational age less than or equal to 32 weeks of gestation and weighing between 750 and 1500 g.
Conditions
- Premature Infants
- Necrotizing Enterocolitis
Interventions
- DIETARY_SUPPLEMENT
-
High dose group
A daily high dose of a mixture of probiotics (Lactobacillus Fermentum CECT 5716 and Bifidobacterium breve CECT 7263), was given orally starting in the first 72 hours of life, until 36+6 weeks of postmenstrual age or discharge The total dose was 1x109 CFU of each of the strains
- DIETARY_SUPPLEMENT
-
Low dose group
A daily low dose of a mixture of probiotics (Lactobacillus Fermentum CECT 5716 and Bifidobacterium breve CECT 7263), was given orally starting in the first 72 hours of life, until 36+6 weeks of postmenstrual age or discharge The total dose was 1x106 CFU of each of the strains
Sponsors & Collaborators
-
University Hospital Virgen de las Nieves
collaborator OTHER -
Hospital Regional de Malaga
collaborator OTHER -
Hospital of Jaen
collaborator OTHER -
Hospital Costa del Sol
collaborator OTHER -
Hospital Universitario Torrecárdenas
collaborator OTHER -
Hospital Universitario Virgen Macarena
collaborator OTHER -
Complejo Hospitalario de Especialidades Juan Ramón Jimenez
collaborator OTHER -
Hospital Universitario de Valme
collaborator OTHER -
Hospitales Universitarios Virgen del Rocío
collaborator OTHER -
Hospital Universitario Puerta del Mar
collaborator OTHER -
Hospital General Universitario Santa Lucia
collaborator OTHER -
Hospital del SAS de Jerez
collaborator OTHER -
José Antonio Hurtado Suazo
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Max Age
- 72 Hours
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-01-10
- Primary Completion
- 2015-01-15
- Completion
- 2020-03-20
Countries
- Spain
Study Locations
More Related Trials
-
The Efficacy and Mechanisms of Oral Probiotics in Preventing Necrotizing Enterocolitis
NCT02552706 ·Status: UNKNOWN ·Phase: NA
-
Multi-strain Probiotics to Prevent Necrotizing Enterocolitis in Very Preterm Infants
NCT06810154 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Role of Probiotic Use in Outcomes of Premature Birth
NCT05710575 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Probiotics in Premature Infants
NCT00727363 ·Status: TERMINATED ·Phase: PHASE3
-
Study the Safety and Efficacy of Probiotics Use in Premature Infants
NCT01891604 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Oral Probiotic Supplementation on the Clinical Status of Very-low-birth-weight Preterm Neonates.
NCT02073214 ·Status: COMPLETED ·Phase: NA
-
A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants
NCT01337921 ·Status: WITHDRAWN ·Phase: NA
-
Probiotics Reduce Incidence of Necrotizing Enterocolitis for Very Low Birth Weight Infants
NCT00540033 ·Status: TERMINATED ·Phase: PHASE2
-
Probiotics for Preterm Infants
NCT06885944 ·Status: NOT_YET_RECRUITING
-
Prebiotics in the Prevention of Necrotizing Enterocolitis
NCT00437567 ·Status: UNKNOWN ·Phase: PHASE2
-
Effects of Probiotic and Prebiotic Combinations on Premature Infants
NCT00282113 ·Status: COMPLETED ·Phase: NA
-
Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies
NCT07233382 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants
NCT04541771 ·Status: UNKNOWN ·Phase: PHASE2
-
Infloran® for Prevention of Necrotizing Enterocolitis
NCT01751477 ·Status: COMPLETED
-
Effect of Oral Probiotic Supplementation on The Rate of Hospital Acquired Infection and Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants
NCT01340469 ·Status: COMPLETED ·Phase: PHASE3
-
Probiotics On Resistant Bacteria Colonization In Preterm Receiving Antibiotics
NCT02178267 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Impact of Type of Probiotic, Delivery Type and Feeding Type on Baby's Microbiota After Dysbiotic Delivery
NCT04304014 ·Status: COMPLETED ·Phase: NA
-
Safety of Lactobacillus Fermentum in Newborn Infants
NCT01346644 ·Status: COMPLETED ·Phase: NA
-
Synbiotics in Patients at RIsk fOr Preterm Birth
NCT05966649 ·Status: RECRUITING ·Phase: NA
-
Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection
NCT06231056 ·Status: COMPLETED ·Phase: NA
-
Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis
NCT00835874 ·Status: TERMINATED ·Phase: NA
-
Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants
NCT01531179 ·Status: COMPLETED ·Phase: PHASE3
-
Probiotics and Intestinal Microbiome in Preterm Infants
NCT03422562 ·Status: COMPLETED ·Phase: PHASE3
-
Probiotics in the Management of Necrotizing Enterocolitis in HIV-exposed Premature Infants
NCT01868737 ·Status: COMPLETED ·Phase: PHASE3
-
Probiotics for the Prevention of Premature Birth and Neonatal Related Morbidity
NCT00303082 ·Status: TERMINATED ·Phase: PHASE3